Rankings
Publications
Search Publications
Cited-By Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Login
Register
Home
Publications
The Novel Oral Typhoid Vaccine M01ZH09 Is Well Tolerated and Highly Immunogenic in 2 Vaccine Presentations
Home
Publications
The Novel Oral Typhoid Vaccine M01ZH09 Is Well Tolerated and Highly Immunogenic in 2 Vaccine Presentations
The Novel Oral Typhoid Vaccine M01ZH09 Is Well Tolerated and Highly Immunogenic in 2 Vaccine Presentations
Beth D. Kirkpatrick
Beth D. Kirkpatrick
KT
Katherine M. Tenney
Katherine M. Tenney
CL
Catherine J. Larsson
Catherine J. Larsson
JO
J. Patrick O’neill
J. Patrick O’neill
CV
Cassandra Ventrone
Cassandra Ventrone
MB
Matthew Bentley
Matthew Bentley
AU
Anthony Upton
Anthony Upton
ZH
Zoë Hindle
Zoë Hindle
CF
Christine Fidler
Christine Fidler
DK
Deborah Kutzko
Deborah Kutzko
RH
Regan Holdridge
Regan Holdridge
CL
Casey LaPointe
Casey LaPointe
See more
Open Access
Publisher Website
Google Scholar
Add to Library
Cite
Download
Share
Download
Download
Download PDF
Download
1 August 2005
journal article
clinical trial
Published by
Oxford University Press (OUP)
in
The Journal of Infectious Diseases
Vol. 192
(3)
,
360-366
https://doi.org/10.1086/431605
Abstract
BackgroundM01ZH09 (Salmonella enterica serovar Typhi [Ty2 aroC− ssaV−] ZH9) is a live oral-dose typhoid vaccine candidate. M01ZH09 was rationally mod
Keywords
IMMUNE RESPONSE
SALMONELLA TYPHI
VACCINATION
VACCINES
TYPHOID
BUFFERS
ENZYME LINKED IMMUNOSPOT ASSAY
BICARBONATE THERAPY
SALMONELLA
LYMPHOCYTE
IMMUNOGLOBULIN G
FLAGELLIN
MUTATION
FEVER
ADVERSE EVENT
ENZYMES
ADULT
INTERFERONS
LIPOPOLYSACCHARIDES
HUMAN LEUKOCYTE INTERFERON
All Articles
Open Access
Cited by 77 articles